PINION JOHN RICHARD (See Remarks) sold 11.0% of their position (6.20K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $856.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2021ACC: 0001209191-21-017561
Officer· See Remarks
Since Mar 2026
+14.94K
Net shares
Net buyer
$856.4K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
21.14K acquired · 6.20K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5.50K
Price / share
—
Trade value
—
% of position
11.9%
3/1/2021
46.30K→51.80K
Common Stock
Direct
Shares
+4.64K
Price / share
—
Trade value
—
% of position
8.9%
3/1/2021
51.80K→56.44K
Common Stock
Direct
Shares
−6.20K
Price / share
$138.17
Trade value
$856.38K
% of position
11.0%
3/1/2021
56.44K→50.24K
Total
Net shares
+3.94K
Net value
-$856.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2021 | A · Award | +5.50K | — | — | 11.9% | 46.30K | 51.80K |
| Common Stock Direct | 3/1/2021 | A · Award | +4.64K | — | — | 8.9% | 51.80K | 56.44K |
| Common Stock Direct | 3/1/2021 | S · Sale | −6.20K | $138.17 | $856.38K | 11.0% | 56.44K | 50.24K |
| Total | +3.94K | -$856.38K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
11K shares
Shares
+11K
Strike price
142.47
Held after
11K
Exercisable
—
3/1/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock11K shares | 3/1/2021 | A · Award | +11K | 142.47 | — | 11K |